Louisville, Colorado — According to state and local development sources, Loxo Oncology, Inc. plans to invest $1,626,575.00 to build out new space in Louisville. The company plans to occupy the new space at 600 Tech Ct Louisville in Louisville, on or about November 1, 2023. According to the company website Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients. Loxo@Lilly is a global organization with team members in Boulder, Colorado; Indianapolis, Indiana; New York City, New York; San Diego, California; South San Francisco, California; Stamford, Connecticut; and Madrid, Spain.

To learn more about Loxo Oncology, Inc., visit http://www.loxooncology.com/

Company Contact:
Josh Bilenker, Chief Executive Officer
https://www.linkedin.com/in/josh-bilenker-58655b14/
203-653-3880

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.